KNSA · Company research
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares (KNSA): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 77.96 | $6,346,591,681.1 | 6170914681.1 | 253.6666666666666667 | — | 8.3347619047619108 | 26.0533320242200328 | 9.7020582177760724 | 136.39198145577237170151 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.